State AGs Bash DOJ's Proposed Opioid Deal With Purdue

Law360 (October 14, 2020, 11:08 PM EDT) -- Dozens of state attorneys general on Wednesday slammed the U.S. Department of Justice's plan to preserve Purdue Pharma as a public beneficiary trust through a proposed settlement that could end federal liability the company faces for its alleged role in the opioid epidemic.

Under the proposed deal announced in September 2019, Purdue Pharma LP would be restructured as a public beneficiary trust, from which drug sale profits from its painkiller OxyContin would go to state and local governments. The company would also donate its drugs for treating opioid addiction.

But the state attorneys general, most of whom are Democrats, told U.S. Attorney General...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!